supplemental funding

Dear Research Advocate, On the Hill: The odds are increasing that members of the Senate will come together again, as they did with several COVID-19 supplemental spending packages, to pass a bipartisan infrastructure bill. It is anticipated the House will follow suit. This is meaningful beyond the clear need to address gaps and frailties in our nation’s infrastructure; it reinforces a too rarely demonstrated truth: if members of Congress are convinced a need is compelling enough, they find a path forward. COVID-19 has taken more than 4.19 million lives worldwide. According to the WHO, each year, more than 15 million people between the ages of 30 and 69 die from a non-communicable disease...
Dear Research Advocate, Earth Day: Today, people around the world are taking action to better the environment and our planet. As the public clearly recognizes , threats to the environment are threats to our health. Check out this evidence-based resource from The Medical Society Consortium on Climate and Health detailing the links between climate change and health. On the Hill: President Biden will give his first address to a joint session of Congress next Wednesday. If the Administration’s initial budget proposal is any indication, he will highlight the importance of robust investment in science & technology. In that context... Take Action Now: The President’s infrastructure package...
Dear Research Advocate, Budget Watch: The Biden Administration has released a “skinny budget,” a glimpse into the more detailed Fiscal Year 2022 budget proposal the President is expected to release in May. Read our statement here . The proposal places a strong emphasis on science, technology, and public health. We firmly believe this emphasis can carry over, on a bipartisan basis, to the Congressional appropriations process. With help from advocates, that is. Here’s one way to weigh in: three “Dear Colleague” letters (requests from one Member of Congress to their colleagues) are circulating in the House right now. Ask your representative to sign on to these letters, which support robust...
Dear Research Advocate, Budget Watch: President Biden is expected to release his first set of spending requests for FY22 on Friday, enabling Congress to begin consideration of the budget for the new fiscal year. The document won’t include the infrastructure and jobs plan the President unveiled last week (read our statement on the plan here ) though Biden officials say the proposals are intended to be complimentary. What will we be looking for in the FY22 budget proposal? Strong funding for NIH, CDC, FDA, NSF, AHRQ, and other key agencies and programs in the science, technology, and public health arenas. We can advocate now - use this editable email to reach out to your members of Congress...
Dear Research Advocate, Biden Administration Plan: The Biden Administration has released “ The American Jobs Plan .” The plan encompasses major investments in R&D, transportation, broadband, clean drinking water, manufacturing, and several other areas. It calls for $180 billion for “R&D and the technologies of the future.” The NSF would receive $50 billion, a portion of which would be for the creation of a technology directorate. The proposal also calls for $30 billion to improve our nation’s pandemic preparedness, including a buildout for BARDA. Research!America issued a statement on the plan. Endless Frontier: The NSF technology directorate included in The American Jobs Plan is...
Dear Research Advocate, Advocacy Then and Now: This letter marks #500 since I began this weekly conversation with you. In the first letter, I spoke out against the Budget Control Act and the severe funding caps it would (and did) impose on strategic imperatives like research. You joined with us to help secure modifications to those budget caps to enable funding increases for NIH and other research agencies. Advocacy works. Now, hundreds of letters later, the FY22 budget cycle is about to begin: reports are that President Biden will release the first details of his FY22 budget request next week, to be followed by a more detailed budget later this spring. It was heartening to hear the...
Dear Research Advocate, The Senate HELP Committee and House Energy and Commerce Committee held hearings this week to review the Biden Administration’s pandemic response and ongoing COVID-19 vaccine distribution with CDC Director Dr. Rochelle Walensky, NIH NIAID Director Dr. Anthony Fauci, HHS Chief Scientific Officer for the COVID Response Dr. David Kessler, and FDA CBER Director Dr. Peter Marks. In their testimonies, the Administration officials underscored how utilizing past scientific discoveries in combination with new partnerships led to the development of COVID-19 vaccines and therapeutics at a record pace. They also spoke to concerns regarding equitable vaccine distribution, and how...
Dear Research Advocate, Never Again: One year ago today, the WHO officially declared COVID-19 a pandemic. Within days, statewide stay-at-home orders began across the U.S., and the road before us became frighteningly uncertain. Across the country, COVID-19 has taken almost 530,000 lives; globally, more than 2.6 million have died. Over the course of a year filled with determination, turmoil, and tragedy, the significance of science and technology became crystal clear. Because of decades of basic research, rapid response science & technology (S&T), and heroic public health efforts by individuals laser-focused on saving lives, we have three safe and effective vaccines, and, as new CDC...
Dear Research Advocate, Women in Science and Technology : March is Women’s History Month. The impact of COVID-19 on the careers of women in STEMM is the focus of a report to be released by the National Academies of Science, Engineering, and Medicine (NASEM) on March 9, 2021. How did the COVID-19 pandemic disrupt the careers of women in academic STEMM during 2020 and how might these disruptions—both positive and negative—shape future progress for women in academic STEMM? The public is invited to a discussion with NASEM committee members Eve J. Higginbotham, University of Pennsylvania; Reshma Jagsi, University of Michigan; and Erick C. Jones, University of Texas at Arlington. Register here ...
Dear Research Advocate, Perseverance and resilience anchor us as we navigate this pandemic. The recent landing of the Perseverance rover on Mars exemplifies the tenacity and commitment underlying breakthrough discoveries in science and technology. COVID-19 Therapeutics: Thanks to the perseverance of extraordinary academic and private sector researchers around the world, we now have an array of therapeutics available for a disease that a year ago was just entering the public consciousness. Earlier today, we hosted a virtual discussion focused on the what, when, and how behind COVID-19 interventions. If you were unable to join us today, I promise you will find the conversation informative,...

Pages

Sidebar Quote

Luck shouldn't play a role in why I'm alive.
Laurie MacCaskill, a seven-year pancreatic cancer survivor